This data supports the finding by Han et al. that GPC3 is a potential suppressor of metastasis as loss of GPC3 was associated with increased lymph node metastasis and poor overall survival (OS) [27]. Here, GPC3 is linked to metastatic malignant neoplasm in the lymph nodes.